Form 4: USANA Health Sciences Director Ding Xia Reports Acquisition of Restricted Stock Units

Director Ding Xia reports acquiring 4,230 restricted stock units in USANA Health Sciences, vesting quarterly starting July 2025.

Summary

• On May 20, 2025, Director Ding Xia reported acquiring 4,230 restricted stock units (RSUs) of USANA Health Sciences Inc.
• Each RSU represents a contingent right to receive one share of USNA common stock.
• The RSUs vest in four equal installments of 25% each, on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
• Following the transaction, Ding Xia directly owns 4,230 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing indicating insider transactions, which doesn't inherently suggest positive or negative implications for the company's performance.

Positives

• The acquisition of restricted stock units by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the RSUs suggests a multi-quarter performance horizon for the director's incentives.

Industry Context

This filing is a routine disclosure related to insider transactions, common in publicly traded companies. It provides transparency regarding the compensation and equity ownership of company directors.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it signals a director's increased alignment with the company's long-term success.

Key Dates

Keywords

USANA Health Sciences, Director, Ding Xia, Restricted Stock Units, RSU, Beneficial Ownership, Form 4, SEC